Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Soluble cytokine receptors TNF-α blocking antibodies for treating spinal disorders mediated by nucleus pulposus

Soluble cytokine receptors TNF-α blocking antibodies for treating spinal disorders mediated by nucleus pulposus

US Patent 7811990 · Granted Oct 12, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Composition for use in the treatment of intervertebral disc-related pain2019
Composition for use in the treatment of intervertebral disc-related pain2019
Composition for use in the treatment of intervertebral misalignment2018
Use of an antibody that blocks TNF-alpha activity for treating a nerve disorder 2011
Use of an antibody that blocks TNF-alpha activity for treating a nerve disorder 2011
Methods for reduction of adhesion formation using cytokine inhibitors2011
Specific TNF-A inhibitors for treating spinal disorders mediated by nucleous pul2011
Specific TNF-A inhibitors for treating spinal disorders mediated by nucleous pul2011
Thalidomide and thalidomide derivatives for treating spinal disorders mediated b2010
Thalidomide and thalidomide derivatives for treating spinal disorders mediated b2010
Use of TNF-alpha inhibitors for treating a nerve disorder mediated by nucleus pu2010
Use of TNF-alpha inhibitors for treating a nerve disorder mediated by nucleus pu2010